RxDoctor Payments Data

Malini Nair

Psychiatry · Winchester, MANPI 1578731998

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $814 of the $1,165 with a category attached, or 69.9%. E.r. Squibb & Sons, L.L.C. accounts for 96.4% of it on its own, with 2 other manufacturers making up the rest.

$1,165in general payments, 2019–2025

Across 5 payments — averaging $232.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$1K
  • Neurocrine Biosciences, Inc.$25
  • Teva Pharmaceuticals USA, Inc.$17
$1,567,216in research payments, 2019–2025

Across 34 payments — averaging $46,095 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$521K
  • Genentech, Inc.$377K
  • E.r. Squibb & Sons, L.L.C.$313K
  • UCB SA$283K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$73K

What the payments were for

  • Travel & lodging$81470%
  • Food & beverage$35030%

General payments by program year

20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,165 in reported general payments places this provider in the 85th percentile of 1,431 psychiatry providers in Massachusetts.

See all psychiatry providers in Massachusetts

Most prescribed under Part D

DrugClaimsCost to plans & patients
NamzaricMemantine Hcl/Donepezil Hcl14$16,116
Donepezil Hcl30$315

Paid to pharmacies, not to this prescriber.

Other psychiatry in Winchester

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →